EuroIntervention PCRonline - Connecting with the community

Just accepted article

Biolimus-eluting versus Everolimus-eluting Stents in Coronary Artery Disease A Pooled Analysis from the NEXT and COMPARE II Randomized Trials

Disclaimer:

As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.

Sign in to download the full article

1. Maasstad Hospital, Rotterdam, NETHERLANDS; 2. Division of Cardiology, University of Fribourg, Switzerland; 3. Division of Cardiology, Saiseikai Fukuoka General Hospital, Fukuoka, Japan; 4. Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan; 5. Netherlands; 6. Department of Cardiovascular Medicine, Kyoto University, Graduate School of Medicine, Kyoto, Japan

Abstract

Aims:This study sought to investigate the safety and efficacy of the biolimus-eluting stent with biodegradable polymer (BP-BES; Nobori, Terumo) compared to the everolimus-eluting stent with durable polymer (DP-EES; Xience V or Prime, Abbott Vascular, or Promus, Boston Scientific).

Methods and results:The all-comers NEXT …

– OR –